The dysregulation of the tubulin–polyglutamylation balance caused by CCP1 mutations has also been found in human neurodegenerative diseases, where it mainly manifests as progressive neurodegeneration in the central and peripheral nervous systems during infancy. Here, AGTPBP1 is linked to neurodegenerative disease.